BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hucl T, Gallmeier E. DNA repair: exploiting the Fanconi anemia pathway as a potential therapeutic target. Physiol Res 2011;60:453-65. [PMID: 21401292 DOI: 10.33549/physiolres.932115] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Chen P, Li J, Jiang H, Lan T, Chen Y. Curcumin reverses cisplatin resistance in cisplatin-resistant lung caner cells by inhibiting FA/BRCA pathway. Tumor Biol 2015;36:3591-9. [DOI: 10.1007/s13277-014-2996-4] [Reference Citation Analysis]
2 Dragana V, Sandra P, Emilija L, Miloš K, Andreja L, Ivana J, Dragan M, Ankica J, Zeljko Z, Marija GŠ, Sanja C, Gordana J. Prevalence of FA-D2 rare complementation group of Fanconi anemia in Serbia. Indian J Pediatr 2014;81:260-5. [PMID: 24317781 DOI: 10.1007/s12098-013-1284-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
3 Chen P, Li J, Jiang HG, Lan T, Chen YC. Curcumin reverses cisplatin resistance in cisplatin-resistant lung caner cells by inhibiting FA/BRCA pathway. Tumour Biol 2015;36:3591-9. [PMID: 25542235 DOI: 10.1007/s13277-014-2996-4] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 6.5] [Reference Citation Analysis]
4 Justo GA, Bitencourt MA, Pasquini R, Castelo-Branco MT, Almeida-Oliveira A, Diamond HR, Rumjanek VM. Immune status of Fanconi anemia patients: decrease in T CD8 and CD56dim CD16+ NK lymphocytes. Ann Hematol 2014;93:761-7. [PMID: 24240977 DOI: 10.1007/s00277-013-1953-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
5 He M, Sun HG, Hao JY, Li YL, Yu JK, Yan YY, Zhao L, Li N, Wang Y, Bai XF, Yu ZJ, Zheng ZH, Mi XY, Wang EH, Wei MJ. RNA interference-mediated FANCF silencing sensitizes OVCAR3 ovarian cancer cells to adriamycin through increased adriamycin-induced apoptosis dependent on JNK activation. Oncol Rep 2013;29:1721-9. [PMID: 23440494 DOI: 10.3892/or.2013.2295] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
6 Jacq X, Kemp M, Martin NM, Jackson SP. Deubiquitylating enzymes and DNA damage response pathways. Cell Biochem Biophys 2013;67:25-43. [PMID: 23712866 DOI: 10.1007/s12013-013-9635-3] [Cited by in Crossref: 66] [Cited by in F6Publishing: 63] [Article Influence: 8.3] [Reference Citation Analysis]
7 Banerjee T, Aggarwal M, Sommers JA, Brosh RM Jr. Biochemical and cell biological assays to identify and characterize DNA helicase inhibitors. Methods 2016;108:130-41. [PMID: 27064001 DOI: 10.1016/j.ymeth.2016.04.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
8 He K, Li Y, Zhu J, Liu H, Lee JE, Amos CI, Hyslop T, Jin J, Lin H, Wei Q, Li Y. Component-wise gradient boosting and false discovery control in survival analysis with high-dimensional covariates. Bioinformatics 2016;32:50-7. [PMID: 26382192 DOI: 10.1093/bioinformatics/btv517] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
9 Eccles LJ, Bell AC, Powell SN. Inhibition of non-homologous end joining in Fanconi Anemia cells results in rescue of survival after interstrand crosslinks but sensitization to replication associated double-strand breaks. DNA Repair (Amst) 2018;64:1-9. [PMID: 29459202 DOI: 10.1016/j.dnarep.2018.02.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
10 Qi J, Zhou J, Tang XQ, Wang Y. Gene Biomarkers Derived from Clinical Data of Hepatocellular Carcinoma. Interdiscip Sci 2020;12:226-36. [PMID: 32297074 DOI: 10.1007/s12539-020-00366-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
11 De Toni EN, Ziesch A, Rizzani A, Török HP, Hocke S, Lü S, Wang SC, Hucl T, Göke B, Bruns C, Gallmeier E. Inactivation of BRCA2 in human cancer cells identifies a subset of tumors with enhanced sensitivity towards death receptor-mediated apoptosis. Oncotarget 2016;7:9477-90. [PMID: 26843614 DOI: 10.18632/oncotarget.7053] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
12 Zhao L, Li N, Yu JK, Tang HT, Li YL, He M, Yu ZJ, Bai XF, Zheng ZH, Wang EH, Wei MJ. RNAi-mediated knockdown of FANCF suppresses cell proliferation, migration, invasion, and drug resistance potential of breast cancer cells. Braz J Med Biol Res 2014;47:24-34. [PMID: 24345874 DOI: 10.1590/1414-431X20132938] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
13 Aggarwal M, Banerjee T, Sommers JA, Iannascoli C, Pichierri P, Shoemaker RH, Brosh RM Jr. Werner syndrome helicase has a critical role in DNA damage responses in the absence of a functional fanconi anemia pathway. Cancer Res 2013;73:5497-507. [PMID: 23867477 DOI: 10.1158/0008-5472.CAN-12-2975] [Cited by in Crossref: 41] [Cited by in F6Publishing: 30] [Article Influence: 4.6] [Reference Citation Analysis]
14 Huang YF, Yeh HY, Soo VW. Inferring drug-disease associations from integration of chemical, genomic and phenotype data using network propagation. BMC Med Genomics 2013;6 Suppl 3:S4. [PMID: 24565337 DOI: 10.1186/1755-8794-6-S3-S4] [Cited by in Crossref: 35] [Cited by in F6Publishing: 15] [Article Influence: 3.9] [Reference Citation Analysis]
15 Obermeier K, Sachsenweger J, Friedl TW, Pospiech H, Winqvist R, Wiesmüller L. Heterozygous PALB2 c.1592delT mutation channels DNA double-strand break repair into error-prone pathways in breast cancer patients. Oncogene 2016;35:3796-806. [PMID: 26640152 DOI: 10.1038/onc.2015.448] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]